Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy
- 5 May 2010
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 87 (6), 652-662
- https://doi.org/10.1038/clpt.2010.57
Abstract
Obesity has emerged as one of the principal worldwide health concerns of the modern era, and there exists a tremendous unmet clinical need for safe and effective therapies to combat this global pande...Keywords
This publication has 35 references indexed in Scilit:
- New central targets for the treatment of obesityBritish Journal of Clinical Pharmacology, 2009
- Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersBritish Journal of Clinical Pharmacology, 2009
- Gut Peptides: Targets for Antiobesity Drug Development?Endocrinology, 2009
- Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin ResistanceCell Metabolism, 2009
- Inhibition of ghrelin O -acyltransferase (GOAT) by octanoylated pentapeptidesProceedings of the National Academy of Sciences, 2008
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studiesProceedings of the National Academy of Sciences, 2008
- Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adultsCell Metabolism, 2006
- Vaccination against weight gainProceedings of the National Academy of Sciences, 2006
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Anorectic and behavioural effects of bupropionGeneral Pharmacology: The Vascular System, 1987